Literature DB >> 19797400

In pursuit of leucine-rich repeat-containing G protein-coupled receptor-5 regulation and function in the uterus.

Xiaofei Sun1, Lindsey Jackson, Sudhansu K Dey, Takiko Daikoku.   

Abstract

Leucine-rich repeat-containing G protein-coupled receptor (LGR)-5 is a recently identified marker of stem cells in adult intestinal epithelium and hair follicles. Because of this characteristic, we studied the status of Lgr5 expression in the mouse uterus under various conditions. Lgr5 is highly expressed in the uterine epithelium of immature mice and is dramatically down-regulated after the mice resume estrous cycles. Surprisingly, whereas its expression is up-regulated in uteri of ovariectomized mice, the expression is down-regulated by estrogen and progesterone via their cognate nuclear receptors, estrogen receptor-alpha and progesterone receptor, respectively. Using a mouse endometrial cancer model, we also found that Lgr5 is highly expressed in the epithelium during the initial stages of tumorigenesis but is remarkably down-regulated in fully developed tumors. Lgr5 is a downstream target of Wnt signaling in the intestine. Genetic evidence shows that either excessive or absence of Wnt signaling dampens Lgr5 expression in the uterus. Collectively, our results show that Lgr5 expression in the mouse uterine epithelium is unique and dynamically regulated under various physiological and pathological states of the uterus, suggesting that this orphan receptor has important functions in uterine biology. However, identifying definitive uterine function of LGR5 will require further investigation using conditional deletion of uterine Lgr5 because systemic deletion of this gene is neonatally lethal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797400      PMCID: PMC2775985          DOI: 10.1210/en.2009-0690

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Roadmap to embryo implantation: clues from mouse models.

Authors:  Haibin Wang; Sudhansu K Dey
Journal:  Nat Rev Genet       Date:  2006-03       Impact factor: 53.242

2.  Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus.

Authors:  S W Curtis; J Clark; P Myers; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Estrogen receptor null mice: what have we learned and where will they lead us?

Authors:  J F Couse; K S Korach
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

4.  Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors.

Authors:  Terrill McClanahan; Sandra Koseoglu; Kathleen Smith; Jeffrey Grein; Eric Gustafson; Stuart Black; Paul Kirschmeier; Ahmed A Samatar
Journal:  Cancer Biol Ther       Date:  2006-04-19       Impact factor: 4.742

5.  Cre-mediated recombination in cell lineages that express the progesterone receptor.

Authors:  Selma M Soyal; Atish Mukherjee; Kevin Y-S Lee; Jie Li; Huaiguang Li; Francesco J DeMayo; John P Lydon
Journal:  Genesis       Date:  2005-02       Impact factor: 2.487

6.  The Intestinal Wnt/TCF Signature.

Authors:  Laurens G Van der Flier; Jacob Sabates-Bellver; Irma Oving; Andrea Haegebarth; Mariagrazia De Palo; Marcello Anti; Marielle E Van Gijn; Saskia Suijkerbuijk; Marc Van de Wetering; Giancarlo Marra; Hans Clevers
Journal:  Gastroenterology       Date:  2006-08-18       Impact factor: 22.682

7.  Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.

Authors:  L M Helvering; M D Adrian; A G Geiser; S T Estrem; T Wei; S Huang; P Chen; E R Dow; J N Calley; J A Dodge; T A Grese; S A Jones; D L Halladay; R R Miles; J E Onyia; Y L Ma; M Sato; H U Bryant
Journal:  Biol Reprod       Date:  2004-12-01       Impact factor: 4.285

8.  G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation.

Authors:  Keiji Tanese; Mariko Fukuma; Taketo Yamada; Taisuke Mori; Tsutomu Yoshikawa; Wakako Watanabe; Akira Ishiko; Masayuki Amagai; Takeji Nishikawa; Michiie Sakamoto
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

9.  Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.

Authors:  Takiko Daikoku; Yasushi Hirota; Susanne Tranguch; Ayesha R Joshi; Francesco J DeMayo; John P Lydon; Lora H Ellenson; Sudhansu K Dey
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

10.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

View more
  14 in total

1.  Expression and clinical significance of SALL4 and LGR5 in patients with lung cancer.

Authors:  Ajay Kumar Gautam; Changming Wang; Jinrong Zeng; Jiying Wang; Jingyan Lu; Jianghong Wei; Guojin Huang; Bifan Mo; Miao Luo; Biwen Mo
Journal:  Oncol Lett       Date:  2015-09-30       Impact factor: 2.967

2.  Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis.

Authors:  Hyesung Kim; Dong Hui Lee; Eunsun Park; Jae Kyung Myung; Jeong Hwan Park; Dong Il Kim; Se Ik Kim; Maria Lee; Younghoon Kim; Chul Min Park; Chang Lim Hyun; Young Hee Maeng; Cheol Lee; Bogun Jang
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  Ovarian LGR5 is critical for successful pregnancy.

Authors:  Xiaofei Sun; Jumpei Terakawa; Hans Clevers; Nick Barker; Takiko Daikoku; Sudhansu K Dey
Journal:  FASEB J       Date:  2014-01-27       Impact factor: 5.191

4.  LGR5 is a promising biomarker for patients with stage I and II gastric cancer.

Authors:  Zhaode Bu; Zhixue Zheng; Lianhai Zhang; Ziyu Li; Yu Sun; Bin Dong; Aiwen Wu; Xiaojiang Wu; Xiaohong Wang; Xiaojing Cheng; Xiaofang Xing; Yingai Li; Hong Du; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

5.  Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.

Authors:  Zhi-Xue Zheng; Yu Sun; Zhao-De Bu; Lian-Hai Zhang; Zi-Yu Li; Ai-Wen Wu; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Jing Cheng; Xiao-Fang Xing; Hong Du; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

6.  Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.

Authors:  Ruoyao Zou; Mingjun Zheng; Mingzi Tan; Haoya Xu; Nannan Luan; Liancheng Zhu
Journal:  Cancer Manag Res       Date:  2020-06-26       Impact factor: 3.989

7.  LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?

Authors:  Burkhard H A von Rahden; Stefan Kircher; Maria Lazariotou; Christoph Reiber; Luisa Stuermer; Christoph Otto; Christoph T Germer; Martin Grimm
Journal:  J Exp Clin Cancer Res       Date:  2011-02-23

8.  LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.

Authors:  Francesca Walker; Hui-Hua Zhang; Annalisa Odorizzi; Antony W Burgess
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

9.  A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.

Authors:  Swetlana Rot; Helge Taubert; Matthias Bache; Thomas Greither; Peter Würl; Alexander W Eckert; Johannes Schubert; Dirk Vordermark; Matthias Kappler
Journal:  BMC Cancer       Date:  2011-10-06       Impact factor: 4.430

Review 10.  Endometrial stem/progenitor cells: the first 10 years.

Authors:  Caroline E Gargett; Kjiana E Schwab; James A Deane
Journal:  Hum Reprod Update       Date:  2015-11-09       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.